All three SPP1 promoter SNPs at−66,−156, and−443 have been surveyed simultaneously in several diseases, including ischemic stroke (10), glioma (15), osteoarthritis (12), cervical spondylotic myelopathy (13), and a variety of cancers (11, 14). This evidence concerns the gene SPP1 and central nervous system cancer.